Stockscreener 앱 받기
17.55
2.82%
-0.51
전일 마감가:
$18.06
열려 있는:
$18.03
하루 거래량:
89,894
Relative Volume:
0.43
시가총액:
$271.85M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-2.06%
1개월 성능:
-10.14%
6개월 성능:
-22.14%
1년 성능:
-0.45%
1일 변동 폭
$17.55
$18.35
1주일 범위
$16.47
$18.94
52주 변동 폭
$6.875
$37.27
Neurogene Inc Stock (NGNE) Company Profile
명칭
Neurogene Inc
전화
(877) 237-5020
주소
535 W 24TH STREET, NEW YORK
NGNE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NGNE
Neurogene Inc
|
17.55 | 279.75M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Neurogene Inc Stock (NGNE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-17 | 개시 | Craig Hallum | Buy |
| 2025-05-16 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-06-27 | 개시 | BMO Capital Markets | Outperform |
| 2024-06-11 | 개시 | Robert W. Baird | Outperform |
| 2024-04-29 | 개시 | Leerink Partners | Outperform |
| 2024-03-21 | 개시 | William Blair | Outperform |
| 2024-01-08 | 개시 | H.C. Wainwright | Buy |
| 2024-01-05 | 개시 | Stifel | Buy |
| 2024-01-04 | 개시 | TD Cowen | Outperform |
모두보기
Neurogene Inc 주식(NGNE)의 최신 뉴스
Aug Macro: Is Neurogene Inc stock risky to hold nowQuarterly Portfolio Report & Real-Time Stock Price Movement Reports - baoquankhu1.vn
Risk Analysis: Can Neurogene Inc outperform under higher oil pricesTrade Ideas & Reliable Momentum Entry Alerts - baoquankhu1.vn
NGNE: NGN-401 shows durable, multi-domain gains in Rett syndrome, advancing toward commercialization - TradingView — Track All Markets
Neurogene (NASDAQ:NGNE) Given “Buy” Rating at HC Wainwright - Defense World
Market Fear: Whats the analyst consensus on Neurogene Inc2025 Market Trends & Daily Volume Surge Signals - baoquankhu1.vn
Short Covering: Whats the analyst consensus on Neurogene IncJuly 2025 WrapUp & Weekly Stock Breakout Alerts - baoquankhu1.vn
HC Wainwright & Co. Reiterates Buy Rating for NGNE with $70 Pric - GuruFocus
Neurogene doses multiple patients in Rett syndrome gene therapy trial By Investing.com - Investing.com Nigeria
Neurogene Inc. Reports Q3 2025 Financial Results - MSN
Stifel reiterates Buy rating on Neurogene stock, cites viable safety margin By Investing.com - Investing.com South Africa
Stifel reiterates Buy rating on Neurogene stock, cites viable safety margin - Investing.com Nigeria
Market Review: Whats the analyst consensus on Neurogene IncWeekly Trend Report & Weekly High Return Forecasts - baoquankhu1.vn
Neurogene doses multiple patients in Rett syndrome gene therapy trial - Investing.com
Neurogene outlines 2026 milestones for NGN-401 Rett therapy - TipRanks
Neurogene Announces Recent Achievements and Anticipated 2026 Key Milestones for NGN-401, a Potential Best-in-Class Gene Therapy for Rett Syndrome - marketscreener.com
Neurogene Inc Announces Key Milestones for NGN-401 Gene Therapy - TradingView — Track All Markets
Boston Herald - FinancialContent
Neurogene Announces Positive Interim Data for NGN-401 - MSN
User | custercountychief.comNeurogene Inc.Common Stock (Nasdaq:NGNE) Stock Quote - FinancialContent
Is Neurogene Inc. stock a good choice for value investors2025 Volatility Report & Safe Capital Allocation Plans - Улправда
Is Neurogene Inc. stock gaining market shareJuly 2025 Macro Moves & Consistent Return Investment Signals - Улправда
What insider purchases suggest about Neurogene Inc. (UU8) stockJuly 2025 Retail & Safe Entry Point Identification - Улправда
Neurogene Inc. (NGNE) Stock Analysis: Uncovering a 208% Potential Upside in Biotechnology - DirectorsTalk Interviews
Will Neurogene Inc. (UU8) stock attract long term capital inflows2025 Winners & Losers & Community Verified Trade Alerts - Улправда
How Neurogene Inc. (UU8) stock correlates with oil marketsAI-Driven Market Analysis & Free Realize Exceptional Returns - Улправда
Will Neurogene Inc. stock benefit from upcoming earnings reportsStock Price Forecasts & Minimal Investment Big Returns - ulpravda.ru
What analysts say about Neurogene Inc UU8 stockStock Liquidity Analysis & Free Stock Predictions and Analysis - Early Times
Shanti Educational Initiatives Limited (539921) Announces Strategic ShiftEarly Times Newspaper Jammu - Early Times
Neurogene to Participate in the 44th Annual J.P. Morgan Healthcare Conference - New Castle News
Genetic medicines firm Neurogene opens its health conference talk online - Stock Titan
Neurogene Inc.Common Stock (NQ: NGNE - FinancialContent
Pullback Watch: Is Neurogene Inc stock a good choice for value investorsJuly 2025 Retail & AI Enhanced Trading Signals - moha.gov.vn
Breakout Move: How Applied Industrial Technologies Inc AT4 stock reacts to monetary easingTrend Reversal & Safe Swing Trade Setup Alerts - moha.gov.vn
Here's Why We're Not Too Worried About Neurogene's (NASDAQ:NGNE) Cash Burn Situation - Sahm
Craig-Hallum Initiates Coverage of Neurogene (NGNE) with Buy Recommendation - MSN
Neurogene Inc. (NASDAQ:NGNE) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Neurogene Inc. (NASDAQ:NGNE) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
What catalysts could drive Neurogene Inc. stock higherPortfolio Diversification Tips & Free Hedging Tactics for Volatile Markets - bollywoodhelpline.com
Sell Signal: Is Neurogene Inc stock gaining market shareJuly 2025 Sentiment & Low Risk High Reward Ideas - moha.gov.vn
Earnings Beat: Is Neurogene Inc stock a good choice for value investorsQuarterly Portfolio Summary & Verified Entry Point Signals - moha.gov.vn
Why Neurogene Inc. stock appeals to dividend seekersQuarterly Profit Summary & Weekly Breakout Watchlists - Улправда
Will Neurogene Inc. stock gain from lower inflationWeekly Trade Report & Daily Price Action Insights - DonanımHaber
Can Neurogene Inc. stock continue upward trend2025 Key Highlights & Expert Verified Movement Alerts - DonanımHaber
Will Neurogene Inc. stock split again soonJuly 2025 Retail & Real-Time Volume Analysis Alerts - Улправда
Will Neurogene Inc. (UU8) stock benefit from Fed rate cutsRecession Risk & AI Powered Market Entry Ideas - DonanımHaber
Momentum Shift: Why Neurogene Inc. stock appeals to dividend seekersWeekly Trade Summary & Weekly High Return Opportunities - Улправда
Can Neurogene Inc. stock maintain operating marginsMarket Risk Report & Precise Trade Entry Recommendations - ulpravda.ru
Can Neurogene Inc. stock deliver surprise earnings beatWeekly Earnings Recap & Risk Managed Trade Strategies - Улправда
Insider Buy: Why Neurogene Inc. stock appeals to dividend seekersQuarterly Portfolio Report & Advanced Technical Analysis Signals - Улправда
Neurogene Earnings Notes - Trefis
Neurogene (NASDAQ:NGNE) Lowered to Sell Rating by Wall Street Zen - MarketBeat
Neurogene Inc (NGNE) 재무 분석
Neurogene Inc (NGNE)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
4.73%
0.92%
자본화:
|
볼륨(24시간):